Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children

Vitamin D vs Placebo in the Treatment of Vague Musculoskeletal Pain in Children

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00944606

Enrollment

Registered

2009-07-23

Start date

2009-07-31

Completion date

2011-08-31

Last updated

2012-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypovitaminosis D

Brief summary

Other studies suggest that low Vitamin D levels may contribute to musculoskeletal pain. Hypothesis: Administration of oral Vitamin D supplements will improve vague musculoskeletal pain in children.

Interventions

DIETARY_SUPPLEMENTVitamin D

2000-3000 IU Vitamin D daily x 6 weeks

OTHERPlacebo candy

candy gum drops

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

5 Years to 14 Years

Healthy volunteers

Yes

Inclusion criteria

* ages 5-14 * healthy * vague musculoskeletal pain without diagnosis

Exclusion criteria

* medications (steroids, seizure medications, birth control pills or shot) * endocrinopathies

Design outcomes

Primary

Measure	Time frame
Lessening of musculoskeletal pain level and frequency	6 weeks

Secondary

Measure	Time frame
Improvement of serum 25 OH Vitamin D level	6 weeks
Decline of serum parathyroid hormone levels	6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026